前往化源商城

2-(5-amino-2,4,9-triazabicyclo[4.3.0]nona-1,3,5,7-tetraen-9-yl)-5-(hydroxymethyl)oxolan-3-ol

更新时间:2025-08-25 11:38:48

2-(5-amino-2,4,9-triazabicyclo[4.3.0]nona-1,3,5,7-tetraen-9-yl)-5-(hydroxymethyl)oxolan-3-ol结构式
2-(5-amino-2,4,9-triazabicyclo[4.3.0]nona-1,3,5,7-tetraen-9-yl)-5-(hydroxymethyl)oxolan-3-ol结构式
品牌特惠专场
常用名 2-(5-amino-2,4,9-triazabicyclo[4.3.0]nona-1,3,5,7-tetraen-9-yl)-5-(hydroxymethyl)oxolan-3-ol 英文名 2-(5-amino-2,4,9-triazabicyclo[4.3.0]nona-1,3,5,7-tetraen-9-yl)-5-(hydroxymethyl)oxolan-3-ol
CAS号 40725-89-1 分子量 250.25
密度 1.75g/cm3 沸点 601.3ºC at 760 mmHg
分子式 C11H14N4O3 熔点 N/A
MSDS N/A 闪点 317.5ºC

 用途


7-(3-脱氧-β-D-红-内呋喃基)-7H-吡咯并[2,3-D]嘧啶-4-胺是嘌呤核苷类似物。嘌呤核苷类似物具有广泛的抗肿瘤活性,靶向惰性淋巴系统恶性肿瘤。这一过程中的抗癌机制依赖于抑制DNA合成、诱导细胞凋亡等[1]。

 名称

英文名 2-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)oxolan-3-ol
英文别名 更多

 生物活性

描述 7-(3-脱氧-β-D-红-内呋喃基)-7H-吡咯并[2,3-D]嘧啶-4-胺是嘌呤核苷类似物。嘌呤核苷类似物具有广泛的抗肿瘤活性,靶向惰性淋巴系统恶性肿瘤。这一过程中的抗癌机制依赖于抑制DNA合成、诱导细胞凋亡等[1]。
相关类别
参考文献

[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.  

 物理化学性质

密度 1.75g/cm3
沸点 601.3ºC at 760 mmHg
分子式 C11H14N4O3
分子量 250.25
闪点 317.5ºC
精确质量 250.10700
PSA 106.42000
LogP 0.23540
InChIKey GAKDEQRUZQIUER-UHFFFAOYSA-N
SMILES Nc1ncnc2c1ccn2C1OC(CO)CC1O
折射率 1.797

 毒性和生态

 上下游产品

上游产品  0

下游产品  1

 靶点实验

查看更多实验

实验名称:Minimum inhibitory concentration required to reduce parainfluenza type 3 induced cyto...
来源:ChEMBL
靶标:Human respirovirus 3
External Id:CHEMBL762062
实验名称:Inhibition of murine leukemia L1210 cell growth
来源:ChEMBL
靶标:L1210
External Id:CHEMBL703775
实验名称:Minimum inhibitory concentration required to reduce incorporation of [4,5-3H]leucine ...
来源:ChEMBL
靶标:L1210
External Id:CHEMBL703778
实验名称:Minimum inhibitory concentration required to reduce Herpes simplex virus type 2 (HSV-...
来源:ChEMBL
靶标:Human alphaherpesvirus 2
External Id:CHEMBL877200
实验名称:Minimum inhibitory concentration required to reduce Herpes simplex virus type 1 (HSV-...
来源:ChEMBL
靶标:Human alphaherpesvirus 1
External Id:CHEMBL694223
实验名称:Minimum inhibitory concentration required to reduce reo virus type 1 induced cytopath...
来源:ChEMBL
靶标:Mammalian orthoreovirus 1
External Id:CHEMBL799910
实验名称:Minimum inhibitory concentration required to reduce vesicular stomatitis virus (VSV) ...
来源:ChEMBL
靶标:Vesicular stomatitis virus
External Id:CHEMBL816363
实验名称:Minimum inhibitory concentration required to reduce incorporation of [methyl-3H]dThd ...
来源:ChEMBL
靶标:L1210
External Id:CHEMBL704382
实验名称:Minimum inhibitory concentration required to reduce Vesicular stomatitis virus (VSV) ...
来源:ChEMBL
靶标:Vesicular stomatitis virus
External Id:CHEMBL816362
实验名称:Minimum inhibitory concentration required to reduce incorporation of [5-3H]-Urd into ...
来源:ChEMBL
靶标:L1210
External Id:CHEMBL704381
共18条,当前第1页,共2页
1
2

 英文别名

Tubercidin-5'-phosphat
tubercidin-5-monophosphate
3'-deoxytubercidin
TUBERCIDIN-5'-O-MONOPHOSPHATE SODIUM SALT
7-deaza-[5']adenylic acid
7-CH-5'-AMP SODIUM SALT
7-DEAZAADENOSINE-5'-O-MONOPHOSPHATE SODIUM SALT
5'-deoxy-5'-(methylthio)tubercidin
tubercidin 5'-phosphate
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。